Prevalence, Predictors, and Management of Gastroesophageal Reflux Disease After Laparoscopic Sleeve Gastrectomy: a Multicenter Cohort Study
Authors:
- Ayman El NakeebANAyman El Nakeeb
- Hassan AldossaryHAHassan Aldossary
- Ahmed ZaidAZAhmed Zaid
- Mohamed El SorogyMSMohamed El Sorogy
- Mohamad ElrefaiMEMohamad Elrefai
- Mohamed AttiaMAMohamed Attia
- Alaa Mostafa SewefyASAlaa Mostafa Sewefy
- Taha KayedTKTaha Kayed
- Mubarak Al-Shari AldawsariMAMubarak Al-Shari Aldawsari
- Mohammed M MohammedMMMohammed M Mohammed
- 10 September 2022
- journal article
- research article
- Published by Springer Nature in Obesity Surgery
- Vol. 32 (11) , 3541-3550
Abstract
Background One of the most popular bariatric procedures is laparoscopic sleeve gastrectomy (LSG), which can either cause or worsen gastroesophageal reflux disease (GERD). Therefore, the goal of this study was to examine the prevalence, predictors, and management of GERD symptoms after LSG. Materials and Methods From January 2017 to January 2022, we looked at patients who had a primary LSG and developed GERD. Before LSG, all patients underwent a barium meal and upper endoscopy. After LSG, barium meal, endoscopy, esophageal manometry, and 24-h pH measurements were performed for selected patients. The diagnosis of GERD is based on the GERD-HRQL questionnaire and upper endoscopy. Results The study included 1537 patients (62.5% women and 37.5% men) with a mean age of 34.4 years. The mean % TWL was 40.7% during a mean follow-up period of 15.9 months. A total of 379 patients (24.7%) experienced postoperative GERD, of whom 328 (21.3%) had postoperative de novo GERD symptoms, 25 (1.6%) had worsened preoperative GERD, and 26 (1.7%) had the same preoperative GERD symptoms. Antral preservation and gastropexy were protective factors against the development of GERD after LSG. LSG was converted to LRYGB in 15.8% of the patients with GERD. The response to medical treatment was observed in 300 (79.2%) patients with GERD. Conclusion Post-LSG GERD presented in 379 patients (24.7%). Antral preservation and gastropexy were protective factors for the development of postoperative GERD after LSG. Medical treatment was the main line of treatment for GERD. Trial registration ClinicalTrials.gov ID: NCT05416645. Graphical abstractKeywords
This publication has 42 references indexed in Scilit:
- Impact of Extent of Antral Resection on Surgical Outcomes of Sleeve Gastrectomy for Morbid Obesity (A Prospective Randomized Study)Obesity Surgery, 2014
- Improvement of Gastroesophageal Reflux Symptoms After Standardized Laparoscopic Sleeve GastrectomyObesity Surgery, 2013
- Laparoscopic Sleeve Gastrectomy: Symptoms of Gastroesophageal Reflux can be Reduced by Changes in Surgical TechniqueObesity Surgery, 2012
- Laparoscopic Treatment of Obese Patients with Gastroesophageal Reflux Disease and Barrett’s Esophagus: a Prospective StudyObesity Surgery, 2012
- International Sleeve Gastrectomy Expert Panel Consensus Statement: best practice guidelines based on experience of >12,000 casesSurgery for Obesity and Related Diseases, 2012
- Effect of sleeve gastrectomy on gastroesophageal reflux disease: a systematic reviewSurgery for Obesity and Related Diseases, 2011
- Symptoms of Gastroesophageal Reflux Following Laparoscopic Sleeve Gastrectomy Are Related to the Final Shape of the Sleeve as Depicted by RadiologyObesity Surgery, 2010
- Global burden of obesity in 2005 and projections to 2030International Journal of Obesity, 2008
- The development of the GERD-HRQL symptom severity instrumentDiseases of the Esophagus, 2007
- Endoscopic assessment of oesophagitis: clinical and functional correlates and further validation of the Los Angeles classificationGut, 1999